{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:44:39Z","timestamp":1768463079811,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.atherosclerosis.2019.08.013","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:18:05Z","timestamp":1566559085000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Reversal of endothelial dysfunction post-immunosuppressive therapy in adult-onset podocytopathy and primary membranous nephropathy"],"prefix":"10.1016","volume":"295","author":[{"given":"Neeraj","family":"Inamdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shallu","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kalmath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0155-928X","authenticated-orcid":false,"given":"Ashok Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Bahuguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ujjwal","family":"Gorsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harbir Singh","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishan Lal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-9107","authenticated-orcid":false,"given":"Raja","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.08.013_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.krcp.2012.04.323","article-title":"Current concepts of the podocyte in NS","volume":"31","author":"Ding","year":"2012","journal-title":"Kidney Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.08.013_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"14","author":"Ross","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.08.013_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0272-6386(12)80742-6","article-title":"Elevated levels of tumor necrosis factor-alpha in the NS in humans","volume":"21","author":"Suranyi","year":"1993","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.08.013_bib4","first-page":"2220","article-title":"Insulin resistance, dyslipidaemia, inflammation and endothelial function in NS","volume":"17","author":"Dogra","year":"2002","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.08.013_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11906-010-0150-2","article-title":"Vascular endothelial function and hypertension: insights and directions","volume":"12","author":"Dharmashankar","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.08.013_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI66843","article-title":"Linking endothelial dysfunction with endothelial cell activation","volume":"123","author":"Liao","year":"2013","journal-title":"J.\u00a0Clin. Investig."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2019.08.013_bib7","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/01.CIR.0000118476.29352.2A","article-title":"Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes","volume":"109","author":"Zal","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.08.013_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/nep.12569","article-title":"Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial","volume":"21","author":"Ramachandran","year":"2016","journal-title":"Nephrology"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.08.013_bib9","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.2007020166","article-title":"A\u00a0randomized, controlled trial of steroids and cyclophosphamide in adults with NS caused by idiopathic membranous nephropathy","volume":"18","author":"Jha","year":"2007","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2019.08.013_bib10","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2014application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.08.013_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ekir.2017.02.004","article-title":"Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide","volume":"2","author":"Ramachandran","year":"2017","journal-title":"Kidney Int. Rep."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.08.013_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.08.013_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin. Nephrol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.08.013_bib14","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.4049\/jimmunol.0900879","article-title":"Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function","volume":"183","author":"Megyeri","year":"1950","journal-title":"J.\u00a0Immunol. Baltim. Md."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2019.08.013_bib15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2215\/CJN.12811216","article-title":"Endothelium-dependent and -independent vascular function in advanced chronic kidney disease","volume":"12","author":"Kopel","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2019.08.013_bib16","first-page":"2220","article-title":"Insulin resistance, dyslipidaemia, inflammation and endothelial function in NS","volume":"17","author":"Dogra","year":"2002","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"issue":"Suppl 2","key":"10.1016\/j.atherosclerosis.2019.08.013_bib17","first-page":"66","article-title":"Endothelial dysfunction in the NS","volume":"60","author":"Caraba","year":"2007","journal-title":"Med. Pregl."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.08.013_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1523-1755.2001.00785.x","article-title":"Vascular function of the peripheral circulation in patients with nephrosis","volume":"60","author":"Watts","year":"2018","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.08.013_bib19","doi-asserted-by":"crossref","first-page":"c185","DOI":"10.1159\/000338352","article-title":"Cytotoxic CD4+CD28null T lymphocytes, systemic inflammation and atherosclerotic risk in patients with chronic kidney disease","volume":"120","author":"Yadav","year":"2012","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2019.08.013_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1824-7288-39-42","article-title":"CD19\u2009+\u2009CD23+ B cells, CD4\u2009+\u2009CD25+ T cells, E-selectin and interleukin-12 levels in children with steroid sensitive NS","volume":"39","author":"Yildiz","year":"2013","journal-title":"Ital. J. Pediatr."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.08.013_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/TP.0b013e3182958552","article-title":"Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients","volume":"96","author":"Mourer","year":"2013","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.08.013_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ckj\/sfx120","article-title":"Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?","volume":"11","author":"Melilli","year":"2018","journal-title":"Clin. Kidney J."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.08.013_bib23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.1993.292","article-title":"The increased risk of coronary heart disease associated with NS","volume":"44","author":"Ordo\u00f1ez","year":"1993","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2019.08.013_bib24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.kint.2015.12.041","article-title":"Patients with primary membranous nephropathy are at high risk of cardiovascular events","volume":"89","author":"Lee","year":"2016","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.08.013_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40620-016-0300-y","article-title":"Thyroid function and cardiovascular events in chronic kidney disease patients","volume":"30","author":"Afsar","year":"2017","journal-title":"J.\u00a0Nephrol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:41:20Z","timestamp":1758156080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019314583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":25,"alternative-id":["S0021915019314583"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of endothelial dysfunction post-immunosuppressive therapy in adult-onset podocytopathy and primary membranous nephropathy","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}